SCHEMBL14224922

SCHEMBL14224922

CCCCCCCOCCCC/C=C\CCCCCCC(=O)O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.79
PPARD Q03181 5/20 0.79
PPARA Q07869 5/20 0.79
F7 P08709 5/20 0.79
F3 P13726 5/20 0.79
TERT O14746 3/20 0.79
PTPN1 P18031 3/20 0.79
HSD17B10 Q99714 3/20 0.79
FABP4 P15090 3/20 0.79
TOP1 P11387 3/20 0.79
MAPT P10636 2/20 0.79
BLM P54132 2/20 0.79
LMNA P02545 2/20 0.79
ALOX15 P16050 2/20 0.79
DUSP3 P51452 2/20 0.79
CYP19A1 P11511 2/20 0.79
PTGS1 P23219 2/20 0.79
NR4A2 P43354 2/20 0.79
SIRT6 Q8N6T7 2/20 0.79
PTPN7 P35236 2/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleic Acid SCHEMBL25336982 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
Oleic Acid SCHEMBL27813085 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
SCHEMBL27162744 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
Stearic Acid SCHEMBL7615219 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
SCHEMBL16320281 1.00 PPARG (0.79) PPARGPPARDPPARAF7F3
SCHEMBL14226205 0.98 PPARG (0.77) PPARGPPARDPPARAF7F3
SCHEMBL3291308 0.97 PPARG (0.74) PPARGPPARDPPARAF7F3
SCHEMBL1602682 0.97 PPARG (0.74) PPARGPPARDPPARAF7F3
SCHEMBL1602681 0.97 PPARG (0.74) PPARGPPARDPPARAF7F3
SCHEMBL10482039 0.97 PPARG (0.73) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080095711-A1 Modulators of Pulmonary Hypertension NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080095711-A1 Modulators of Pulmonary Hypertension HIF1AN, PTGIS, PTGIR PPARG 296/4885PPARD 460/4885PPARA 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.